A prospective, randomized, controlled, multicenter study of a real-time, intraoperative probe for positive margin detection in breast-conserving surgery - 22/08/11
, Zvi Kaufman, M.D. b, Shlomo Lelcuk, M.D. c, Itzhak Pappo, M.D. d, Tami Karni, M.D. d, Shlomo Schneebaum, M.D. e, Rona Spector, M.D. c, Asher Schindel, M.D. c, Dan Hershko, M.D. f, Moshe Zilberman, M.D. g, Joel Sayfan, M.D. h, Yuri Berlin, M.D. h, Amram Hadary, M.D. i, Oded Olsha, M.D. j, Haim Paran, M.D. b, Mordechai Gutman, M.D. b, Moshe Carmon, M.D. j
Corresponding author. Tel.: +972-2-5844111; fax: +972-2-5844232Abstract |
Background |
This randomized, double-arm trial was designed to study the benefit of a novel device (MarginProbe, Dune Medical Devices, Caesarea, Israel) in intraoperative margin assessment for breast-conserving surgery (BCS) and the associated reduction in reoperations.
Methods |
In the device group, the probe was applied to the lumpectomy specimen and additional tissue was excised according to device readings. Study arms were compared by reoperation rates and by correct surgical reaction confirmed by histology.
Results |
Three hundred patients were enrolled. Device use was associated with improved correct surgical reaction, defined as additional re-excision in all histologically detected positive margins, with tumor within 1 mm of inked margin. The repeat lumpectomy rate was significantly reduced by 56% in the device arm: 5.6% versus 12.7% in the control arm. There were no differences in excised tissue volume or cosmetic outcome.
Conclusions |
Intraoperative use of the MarginProbe for positive margin detection is safe and effective in BCS and decreases the rate of repeat operations.
Le texte complet de cet article est disponible en PDF.Keywords : Breast cancer, Breast-conserving surgery, Intraoperative margin assessment, Surgical margins, Lumpectomy, Positive margins
Plan
| Supported by Dune Medical Devices, Caesarea, Israel. |
Vol 196 - N° 4
P. 483-489 - octobre 2008 Retour au numéro
Article précédent
- Scientific Presentation Award: The combination of axillary ultrasound and ultrasound-guided biopsy is an accurate predictor of axillary stage in clinically node-negative breast cancer patients
- Dana M. Holwitt, Mary Ellen Swatske, William E. Gillanders, Barbara S. Monsees, Feng Gao, Rebecca L. Aft, Timothy J. Eberlein, Julie A. Margenthaler
- Internal mammary sentinel node biopsy for breast cancer
- Eli Avisar, Manuel A. Molina, Michelino Scarlata, Frederick L. Moffat
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?